Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Pharmacoepidemiology and Drug Safety|December 5, 2019
The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety DatalinkWei Yu, Chengyi Zheng, Fagen Xie, et al.
Vaccine|April 25, 2022
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemicStanley Xu, Vennis Hong, Lina S Sy, et al.
The Journal of Infectious Diseases|February 24, 2011
Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009Luke F Chen, Natalie J M Dailey, Agam K Rao, et al.
JAMA Network Open|November 6, 2024
Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical TrialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.
Pharmacoepidemiology and Drug Safety|August 18, 2024
Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety DatalinkThomas G Boyce, David L McClure, Kayla E Hanson, et al.
The Journal of Pediatrics|January 21, 2026
Incident Epilepsy and Vaccination Status or Vaccine Aluminum Exposure in Children Under Age 4David L McClure, Kayla E Hanson, Maria E Sundaram, et al.
American Journal of Epidemiology|October 4, 2022
Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record DataJennifer C Nelson, Ernesto Ulloa-Pérez, Onchee Yu, et al.
MMWR. Morbidity and Mortality Weekly Report|June 18, 2025
Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Agam K Rao, Faisal S Minhaj, Rosalind J Carter, et al.
Pediatrics|April 29, 2015
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University OutbreakLucy A McNamara, Alice M Shumate, Peter Johnsen, et al.
Pageof 6